Clinical Trial: A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)

U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07137910) titled 'A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)' on Aug. 15.

Brief Summary: This study is an open-label, multicenter phase II clinical study to evaluate the efficacy and safety of AHB-137 injection in participants with CHB previously treated with NA.

Study Start Date: Aug. 27

Study Type: INTERVENTIONAL

Condition: Chronic Hepatitis B

Intervention: DRUG: AHB-137

AHB-137 will be injected

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Ausper Biopharma Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....